Lil Nas X opened up about his struggles with mental health in a series of candid videos.
Three Black female local prosecutors aligned with a movement to end racial disparities in the U.S. criminal justice system are seen as contenders for top federal prosecutor posts, sources said, a potential sign of how President Joe Biden aims to reform the Justice Department. Rachael Rollins in Boston, Sherry Boston in Atlanta and Satana Deberry in Durham, North Carolina have been approached by congressional Democrats or members of Biden's transition team about potentially leading some of the department's 93 U.S. Attorney's Offices, sources familiar with the matter said.
The daily toll reached 1,910 on Wednesday, Brazil's highest figure since the pandemic started.
The "Global Textured Soy Protein Market Growth, Trends and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
Kyal Sin, known as Angel, was one of 38 people killed in anti-coup protests on Wednesday.
Join Pepperdine Graziadio for its 9th Annual Socially, Environmentally, and Ethically Responsible (SEER) Symposium on Wednesday, March 24, 2021 from 11:30 AM to 1 PM. This year’s event theme, Seizing The Moment, will feature a powerhouse of industry-leading speakers to discuss the vital need for incorporating ethical, environmental, and sustainable practices within the evolving business landscape.
British Airways has struck a deal with a COVID-19 testing kit provider as airlines prepare for the desperately-needed restart of summer travel, which is likely to include tests for passengers. But it is not yet clear how mass foreign travel will resume. British Airways (BA) said on Thursday its new testing deal would make it easier for travellers to take a test when abroad to fulfil any requirements for their return to Britain.
The Nasdaq undercut lows while Amazon and stay-at-home winners like Zoom tumbled below 200-day lines. But the market rally isn't all dead yet.
Abu Dhabi state fund Mubadala began taking orders for two-tranche euro-denominated bonds comprising six- and 13-year paper, a document showed on Thursday. Initial guidance was around 85 basis points (bps) over mid-swaps for the six-year notes and between 105 and 110 bps over mid-swaps for the 13-year notes, the document from one of the banks on the deal showed. The bonds are being issued through Mamoura Diversified Global Holding (MDGH), a wholly-owned subsidiary of Mubadala Investment Company.
Most Central European currencies and stocks weakened on Thursday as a turnaround in U.S. bond yields dented risk appetite, while markets eyed further lockdown measures in Hungary to curb the spread of the new coronavirus. The Hungarian forint dropped 0.2% at 364.7500 per euro, while the Polish zloty fell 0.1%. "The Polish zloty is suffering from the epidemic situation, where restrictions are still maintained due to the increase in cases related to the third wave of the pandemic."
Hosted by Jason Biggs, CHERRIES WILD is a fast-paced half-hour game show that features two rounds of pop culture trivia gameplay. This week's contestants, Gwen and Cara, try and "Solve the Slots" in hopes of getting one step closer to winning the $250,000 jackpot. Watch as this female duo spins the reels on the enormous slot machine, as they attempt to capture all five Wild Cherries to win the ultimate prize.
Books titled “Trees in Trouble” and “How We’re F—ing Up Our Planet” scream out from the shelves of Barnes and Noble’s nature and wildlife section between reassuring tomes on hummingbirds and wildflowers. As the warming world faces raging forest fires, rising seas and increasingly erratic weather, the United States has seen a boom in books about climate change. A Yale University survey released in December found that 66% of Americans were either somewhat or very worried about climate change, up from 53% in 2011.
The "IoT Data Management and Analytics Market by Technology, Infrastructure, Deployment Model (Cloud vs. Premise), Solutions, Applications and Services in Industry Verticals 2021 - 2026" report has been added to ResearchAndMarkets.com's offering.
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform; By End-Use; By Product; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global Point of Care (PoC) diagnostics market is expected to reach US$ 24.70 billion by 2028, according to the study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.The global Point of Care (PoC) diagnostics market is driven by continuous technological advancement in the form of miniaturization of devices, growing preference of patients towards home care, and consistent decline in prices due to inflow of innovative market players. Price reduction increases product penetration, owing to higher affordability among consumers.The growing prevalence of target diseases such as cancer, diabetes, cardiovascular diseases and infectious diseases is expected to drive Point of Care (PoC) diagnostics industry. Cardiovascular diseases are one of the most fatal disorders and are the leading cause of death across the globe. The high presence of unmet medical needs pertaining to this disease and the subsequent rise observe in patient awareness levels in this region is expected to boost the demand for Point of Care (PoC) diagnostics.Segment Highlights Glucose testing segment accounted for the largest revenue share in 2020. Regular glucose testing is of paramount importance for diabetic patients. As per the Diabetes Control and Complications Trial, the use of blood glucose monitors leads to lesser disease complications. Point of Care (PoC) glucose monitors assisting in periodic monitoring of blood glucose helps doctors decide suitable treatment patterns.Clinics were the largest end-use segment accounting for major market share in 2020. High procedure volumes associated with these establishments is one of the primary reasons attributing to its large share.North America was the largest regional market for revenue generation in from Point of Care (PoC) devices in 2020. Growing geriatric population base and the presence of higher medical expenditure levels are some key factors attributing to its largest share.The leading players in the point of care (PoC) diagnostic market include Sekisui Diagnostics LLC, Trinity Biotech PLC, International Technidyne Corporation (ITC), Nipro Diagnostics Inc, Becton Dickinson & Company, Danaher Corporation, Siemens Healthcare GmbH, Roche Ltd. Key Topics Covered: 1. Introduction1.1. Report Description1.1.1. Objectives of the Study1.1.2. Market Scope1.1.3. Assumptions1.2. Stakeholders2. Executive Summary2.1. Market Highlights3. Research Methodology3.1. Overview3.1.1. Data Mining3.2. Data Sources3.2.1. Primary Sources3.2.2. Secondary Sources4. Point of Care (PoC) Diagnostics Market Insights4.1. Point of Care (PoC) Diagnostics - Industry snapshot4.2. Point of Care (PoC) Diagnostics Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Growing prevalence of infectious diseases4.2.1.2. Rising preference towards home healthcare4.2.2. Restraints and Challenges4.2.2.1. Product recalls4.3. Porter's Five Forces Analysis4.3.1. Bargaining Power of Suppliers (Moderate)4.3.2. Threats of New Entrants: (Low)4.3.3. Bargaining Power of Buyers (Moderate)4.3.4. Threat of Substitute (Moderate)4.3.5. Rivalry among existing firms (High)4.4. PESTLE Analysis4.5. Point of Care (PoC) Diagnostics Market Industry trends5. Point of Care (PoC) Diagnostics Market Assessment by Product5.1. Key Findings5.2. Introduction5.2.1. Global Point of Care (PoC) Diagnostics Market, By Product, 2016-2028 (USD Million)5.3. Glucose Testing5.3.1. Global Point of Care (PoC) Diagnostics Market, by Glucose Testing, by Region, 2016-2028 (USD Million)5.4. Hb1Ac Testing5.4.1. Global Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, by Region, 2016-2028 (USD Million)5.5. Coagulation5.5.1. Global Point of Care (PoC) Diagnostics Market, by Coagulation, by Region, 2016-2028 (USD Million)5.6. Fertility5.6.1. Global Point of Care (PoC) Diagnostics Market, by Fertility, by Region, 2016-2028 (USD Million)5.7. Infectious Diseases5.7.1. Global Point of Care (PoC) Diagnostics Market, by Infectious Diseases, by Region, 2016-2028 (USD Million)5.7.2. HIV5.7.2.1. Global Point of Care (PoC) Diagnostics Market, by HIV, by Region, 2016-2028 (USD Million)5.7.3. Clostridium Difficile5.7.3.1. Global Point of Care (PoC) Diagnostics Market, by Clostridium Difficile, by Region, 2016-2028 (USD Million)5.7.4. HBV5.7.4.1. Global Point of Care (PoC) Diagnostics Market, by HBV, by Region, 2016-2028 (USD Million)5.7.5. Cardiac Markers5.7.5.1. Global Point of Care (PoC) Diagnostics Market, by Cardiac Markers, by Region, 2016-2028 (USD Million)5.7.6. Thyroid Stimulating Hormone5.7.6.1. Global Point of Care (PoC) Diagnostics Market, by Thyroid Stimulating Hormone, by Region, 2016-2028 (USD Million)5.7.7. Hematology5.7.7.1. Global Point of Care (PoC) Diagnostics Market, by Hematology, by Region, 2016-2028 (USD Million)5.7.8. Primary Care Systems5.7.8.1. Global Point of Care (PoC) Diagnostics Market, by Primary Care Systems, by Region, 2016-2028 (USD Million)5.7.9. Decentralized Clinical Chemistry5.7.9.1. Global Point of Care (PoC) Diagnostics Market, by Decentralized Clinical Chemistry, by Region, 2016-2028 (USD Million)5.7.10. Feces5.7.10.1. Global Point of Care (PoC) Diagnostics Market, by Feces, by Region, 2016-2028 (USD Million)5.7.11. Lipid Testing5.7.11.1. Global Point of Care (PoC) Diagnostics Market, by Lipid Testing, by Region, 2016-2028 (USD Million)5.7.12. Cancer Marker5.7.12.1. Global Point of Care (PoC) Diagnostics Market, by Cancer Marker, by Region, 2016-2028 (USD Million)5.7.13. Blood Gas/Electrolytes5.7.13.1. Global Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, by Region, 2016-2028 (USD Million)5.7.14. Ambulatory Chemistry5.7.14.1. Global Point of Care (PoC) Diagnostics Market, by Ambulatory Chemistry, by Region, 2016-2028 (USD Million)5.7.15. Drug Abuse Testing5.7.15.1. Global Point of Care (PoC) Diagnostics Market, by Drug Abuse Testing, by Region, 2016-2028 (USD Million)5.7.16. Urinalysis5.7.16.1. Global Point of Care (PoC) Diagnostics Market, by Urinalysis, by Region, 2016-2028 (USD Million)6.7. Global Point of Care (PoC) Diagnostics Market, by Platform7.1. Key Findings7.2. Introduction7.2.1. Global Point of Care (PoC) Diagnostics Market, By Platform, 2016-2028 (USD Million)7.3. Lateral Flow Assays7.3.1. Global Point of Care (PoC) Diagnostics Market, by Lateral Flow Assays, By Region, 2016-2028 (USD Million)7.4. Dipsticks7.4.1. Global Point of Care (PoC) Diagnostics Market, by Dipsticks, by Region, 2016-2028 (USD Million)7.5. Microfluidics7.5.1. Global Point of Care (PoC) Diagnostics Market, by Microfluidics, by Region, 2016-2028 (USD Million)7.6. Molecular Diagnostics7.6.1. Global Point of Care (PoC) Diagnostics Market, by Molecular Diagnostics, by Region, 2016-2028 (USD Million)7.7. Immunoassays7.7.1. Global Point of Care (PoC) Diagnostics Market, by Immunoassays, by Region, 2016-2028 (USD Million)8. Global Point of Care (PoC) Diagnostics Market, by End-Use8.1. Key Findings8.2. Introduction8.2.1. Global Point of Care (PoC) Diagnostics Market, By End-Use, 2016-2028 (USD Million)8.3. Clinics8.3.1. Global Point of Care (PoC) Diagnostics Market, by Clinics, By Region, 2016-2028 (USD Million)8.3.2. Physician Office8.3.2.1. Global Point of Care (PoC) Diagnostics Market, by Physician Office, By Region, 2016-2028 (USD Million)8.3.3. Pharmacy & Retail Clinics8.3.3.1. Global Point of Care (PoC) Diagnostics Market, by Pharmacy & Retail Clinics, By Region, 2016-2028 (USD Million)8.3.4. Non-practice Clinics8.3.4.1. Global Point of Care (PoC) Diagnostics Market, by Non-practice Clinics, By Region, 2016-2028 (USD Million)8.3.5. Urgent Care Clinic8.3.5.1. Global Point of Care (PoC) Diagnostics Market, by Urgent Care Clinic, By Region, 2016-2028 (USD Million)8.4. Hospitals8.4.1. Global Point of Care (PoC) Diagnostics Market, by Hospitals, By Region, 2016-2028 (USD Million)8.5. Home8.5.1. Global Point of Care (PoC) Diagnostics Market, by Home, by Region, 2016-2028 (USD Million)8.6. Assisted Living Healthcare Facilities8.6.1. Global Point of Care (PoC) Diagnostics Market, by Assisted Living Healthcare Facilities, by Region, 2016-2028 (USD Million)8.7. Laboratory8.7.1. Global Point of Care (PoC) Diagnostics Market, by Laboratory, by Region, 2016-2028 (USD Million)9. Point of Care (PoC) Diagnostics Market Assessment by Geography9.1. Key findings9.2. Introduction9.2.1. Point of Care (PoC) Diagnostics Market Assessment, By Geography, 2016-2028 (USD Million)9.3. Point of Care (PoC) Diagnostics Market - North America9.4. Point of Care (PoC) Diagnostics Market - Europe9.5. Point of Care (PoC) Diagnostics Market - Asia-Pacific9.6. Point of Care (PoC) Diagnostics Market - Middle East & Africa9.7. Point of Care (PoC) Diagnostics Market - Latin America10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.1.1. Expansion10.1.2. Acquisition10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Roche Diagnostics11.1.1. Company Overview11.1.2. Financial Performance11.1.3. Product Benchmarking11.1.4. Recent Developments11.2. Abbott Laboratories11.2.1. Company Overview11.2.2. Financial Performance11.2.3. Product Benchmarking11.2.4. Recent Developments11.3. Siemens Healthcare11.3.1. Company Overview11.3.2. Financial Performance11.3.3. Product Benchmarking11.3.4. Recent Developments11.4. Becton, Dickinson and Company11.4.1. Company Overview11.4.2. Financial Performance11.4.3. Product Benchmarking11.4.4. Recent Developments11.5. Johnson & Johnson11.5.1. Company Overview11.5.2. Financial Performance11.5.3. Product Benchmarking11.5.4. Recent Developments11.6. Danaher Corporation11.6.1. Company Overview11.6.2. Financial Performance11.6.3. Product Benchmarking11.6.4. Recent Developments11.7. Chembio Diagnostic Systems11.7.1. Company Overview11.7.2. Financial Performance11.7.3. Product Benchmarking11.7.4. Recent Developments11.8. EKF Diagnostics11.8.1. Company Overview11.8.2. Financial Performance11.8.3. Product Benchmarking11.8.4. Recent Developments11.9. AccuBioTech11.9.1. Company Overview11.9.2. Financial Performance11.9.3. Products/Product Benchmarking11.9.4. Recent DevelopmentsFor more information about this report visit https://www.researchandmarkets.com/r/f9iq1x CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
nextmarkets, the innovative and commission-free online broker, receives $30 million in a Series B financing round. The additional capital is intended to further accelerate the European expansion of the FinTech company, which was founded in Cologne in 2014, and to establish nextmarkets as the leading neobroker in Europe. In addition to Germany and Austria, six further countries - the United Kingdom, Portugal, the Netherlands, France, Spain and Italy - were launched at the end of 2020. The financing round closes out a successful 2020 financial year for nextmarkets, in which the company was able to multiply all KPIs such as the number of executed transactions, customer deposits, as well as the number of customers.
Barcelona football club on Thursday lost a bid before the EU's top court to overturn a claim it received unfair state aid through tax breaks.
Security has been tightened around the U.S. Capitol in Washington - scene of a deadly assault in January - after police warned that a militia group might try to attack it on Thursday, an important day in the calendar for some pro-Trump conspiracy theorists. March 4 is the day when believers in the baseless QAnon conspiracy have claimed that former President Donald Trump, defeated by President Joe Biden in the Nov. 3 election, will be sworn in for a second term in office. An unidentified group of "militia violent extremists" discussed plans in February to "take control of the U.S. Capitol and remove Democratic lawmakers on or about March 4," according to a bulletin issued on Tuesday by the Department of Homeland Security and the Federal Bureau of Investigation.
The "Aircraft Actuator Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, System, and End User" report has been added to ResearchAndMarkets.com's offering.
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) no longer have the U.S. COVID-19 vaccine market to themselves. Johnson & Johnson (NYSE: JNJ) is now scrambling to crank up capacity to ship 100 million doses of its vaccine in the first half of 2021. In this Motley Fool Live video recorded on Feb. 24, 2021, Fool.com contributors Keith Speights and Brian Orelli discuss how J&J's vaccine might shake up the U.S. vaccine market.
The European Union is planning to extend its export authorisation scheme for COVID-19 vaccines to the end of June, two EU sources told Reuters on Thursday, in a move that could reignite tensions with countries who rely on shots made in the EU. The mechanism was set up at the end of January as a reaction to vaccine makers' announcements of delays in the deliveries of COVID-19 vaccines to the EU. It is due to expire at the end of March, but the European Commission wants to extend it through June, the two officials said.
2600Hz, a leading provider of unified business communications and the world-renowned KAZOO platform, is excited to announce it will be a Gold Sponsor of Cavell's Cloud Comms Summit Europe virtual event. The summit, which is the biggest Service Provider event in Europe, will be held virtually on March 17th and 18th and will feature main stage keynotes, breakout sessions, and panel discussions, as well as opportunities for attendees to explore the virtual expo.
Yahoo Home